ZenaTech, Inc. (NASDAQ: ZENA) (FSE: 49Q) (BMV: ZENA), a technology solutions provider specializing in AI-powered drones, Drone as a Service (DaaS), enterprise software and quantum computing, announced that its ZenaDrone subsidiary has signed a memorandum of understanding (MOU) with Rattler Medical Inc. to develop and manufacture a drone-based battlefield blood delivery system. The proposed system will combine ZenaDrone's cargo drone capabilities with Rattler Medical's temperature-controlled blood transport containers to deliver blood to military medical personnel more quickly while reducing reliance on ground transportation in combat environments.
Under the agreement, the companies plan to develop and test a flying prototype within two to three months, evaluating delivery methods that include aerial release and landing-based deployment. ZenaDrone is targeting a demonstration at a U.S. military facility in summer 2027. The initiative expands ZenaTech's defense portfolio into battlefield medical logistics, with the companies seeking to improve blood resupply capabilities and reduce risks associated with transporting medical supplies through contested areas. For full details, see the complete press release.
The collaboration addresses a critical challenge in military medicine: delivering blood products to forward-deployed medical personnel quickly and safely. Ground transportation in combat zones is often slow and vulnerable to attack, potentially delaying life-saving transfusions. By using drones, the system aims to bypass these risks and provide timely resupply. The integration of Rattler Medical's temperature-controlled containers ensures that blood remains viable during transport, a key requirement for medical use.
ZenaTech's move into battlefield medical logistics represents a strategic expansion of its defense offerings. The company already provides AI autonomy drone platforms for commercial, government, and defense sectors, including intelligence, surveillance, reconnaissance (ISR), cargo, and counter-UAS applications for U.S. defense and NATO allies. This new initiative could open additional opportunities within military medical supply chains, a niche that demands high reliability and precision. As noted in the ZenaTech company profile, the firm is executing an acquisition-led DaaS roll-up strategy and investing in next-generation technologies such as drone swarms and quantum computing.
The planned demonstration in summer 2027 will be a key milestone, potentially attracting further defense contracts. If successful, the system could be adopted by other military forces, enhancing ZenaTech's position in the defense market. The company's operating footprint spans North America, Europe, the Middle East, Asia, and Australia, providing a broad base for marketing such solutions. More information about ZenaTech is available at https://www.zenatech.com/.
This announcement was distributed through DefenseWireNews, a specialized communications platform focused on defense contractors and aerospace firms. DefenseWireNews is part of the Dynamic Brand Portfolio at IBN, which offers wire solutions via InvestorWire and other services. The platform's reach includes editorial syndication to 5,000+ outlets and social media distribution, enhancing visibility for announcements like this. For terms and disclaimers, see https://www.DefenseWireNews.com/Disclaimer.
